Company Search:
Advanced Search
Sponsored Links
Oryzon Genomics Sa Company Snapshot
Oryzon Genomics Sa operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Oryzon Genomics Sa with three other miscellaneous service companies in Europe: Realm Therapeutics PLC of the United Kingdom (2016 sales of £644,819.07 [US$885,742.82 ] of which 100% was Health Sciences), Silence Therapeutics Plc of the United Kingdom (£770,000.00 [US$1.06 million] ), and Medical Prognosis Institute A/S which is based in Denmark (4.99 million Danish Kroner [US$816,380.68 ] ).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Oryzon Genomics Sa
  Stock Performance Chart for Oryzon Genomics Sa
  Stock Data: Recent Stock Performance:
  Current Price (1/12/2018): 2.96
(Figures in Euro)
1 Week -1.0%   13 Weeks 0.7%  
4 Weeks 54.7%   52 Weeks -36.1%  
Oryzon Genomics Sa Key Data:
  Ticker: ORY Country: Spain
  Exchanges: MAD Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2016 Sales 735,312
(Year Ending Jan 2017).
Employees: 37
  Currency: Euro Market Cap: 98,936,881
  Fiscal Yr Ends: December Shares Outstanding: 33,481,178
  Share Type: Accion Closely Held Shares: 10,536,711
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.